Blog

Anirban Maitra: The Revolution Medicines siblings

Anirban Maitra/X

Jan 15, 2025, 14:22

Anirban Maitra: The Revolution Medicines siblings

Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center, shared a post on X:

“The Revolution Medicines siblings – Darax, Eli and Zold.

RMC-6236 (RAS ON MULTI) = DaraxONRASib.
RMC-6291 (12C ON) = EliONRASib.
RMC-9805 (12D ON) = ZoldONRASib.

At least that’s how I will remember their names. Via JPM25.”

Dr. Anirban Maitra serves as a Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center since August 2013, and directs the Sheikh Ahmed Pancreatic Cancer Research Center. He leads an NCI-funded laboratory dedicated to pancreatic cancer research, focusing on genetics and molecular pathology in human and mouse models. His research aims to advance early detection and interception strategies to enhance patient survival rates in pancreatic cancer.

Anirban Maitra cancer Darax DaraxONRASib Eli EliONRASib fight against cancer Global fight against cancer OncoDaily Oncology Pathology Revolution Translational Molecular Pathology UT MD Anderson Cancer Center ZoldONRASib

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage